Cheminpharma was founded in March 2007 by Dr. Uday Khire with a vision to create a reliable, flexible, and knowledgeable chemistry focused preclinical drug discovery services company. We, at Cheminpharma strive hard to provide best possible drug discovery services for our partners in a cost effective manner. Drug discovery is our passion. Cheminpharma’s commitment begins with its scientists. Our scientists have direct experience of pre-clinical drug discovery from small biotechnology to large pharmaceutical companies with record of several patents, patent applications and publications. We leverage our deep industry experience to provide the most effective strategic, operational and project management resources to our customers. Since the inception of Cheminpharma, we have collaborated and partnered with small and large companies and have made several important contributions. Cheminpharma maintains premium location in New Haven at 25 Science Park at Yale, a block away from Yale University and a growing presence in Pune, India.

In addition to our focus on drug discovery services, we are active in licensing and developing key products that can be used in drug discovery process. One such novel product licensed-in from the Stanford University is called Shield-1. Shield-1 is a cell permeable small molecule used to quickly and reversibly control cellular levels of proteins of interest.